ALEC · Alector, Inc. · Executive Compensation

$2.20 +0.10 (+4.76%) Q2 2025 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$234.48M

111.66M

Volume · Oct 28 1.9M Avg daily vol (3M) 3.26M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	Co-founder, Chief Executive Officer	$678,100	—	$422,876	$558,216	$325,488	$10,338	$1,995,018
Dr. Sara Kenkare-Mitra	Former President and Head of Research and Development	$614,301	—	$77,710	$17,810	$314,200	$551,129	$1,575,150
Neil Berkley	Chief Financial Officer and Chief Business Officer	$455,000	$91,000	$128,135	$219,202	$152,880	$6,242	$1,052,459

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	Co-founder, Chief Executive Officer	$674,808	—	$2,777,775	—	$203,430	$10,328	$3,666,341
Dr. Sara Kenkare-Mitra	President and Head of Research and Development	$624,367	—	$1,365,000	—	$552,992	$7,322	$2,549,681
Neil Berkley	Chief Financial Officer and Chief Business Officer	$350,000	—	$1,816,657	—	$117,214	$5,955	$2,289,826
Marc Grasso	Chief Financial Officer	$514,777	—	$984,620	—	$182,230	$6,242	$1,687,869
Gary Romano	M.D., Ph.D. Chief Medical Officer	$528,963	—	$838,929	—	$187,686	$8,564	$1,564,142

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	Co-founder, Chief Executive Officer	$653,625	—	$2,576,448	$614,323	$400,000	$10,611	$4,255,007
Dr. Sara Kenkare-Mitra	President and Head of Research and Development	$598,500	—	$1,060,128	$252,684	$687,580	$7,322	$2,606,214
Marc Grasso	Chief Financial Officer	$496,800	—	$797,040	$190,092	$225,672	$6,242	$1,715,846
Gary Romano	M.D., Ph.D. Chief Medical Officer	$502,312	—	$699,840	$166,910	$241,295	$8,564	$1,618,921

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Sara Kenkare-Mitra	President and Head of Research and Development	$570,000	—	$3,018,736	$4,662,171	$612,180	$7,322	$8,870,409
Marc Grasso	Chief Financial Officer	$432,923	$103,000	$337,741	$4,935,992	$200,448	$1,676	$6,011,780
Gary Romano	M.D., Ph.D. Chief Medical Officer	$289,872	—	$1,038,345	$2,451,835	$118,682	$7,165	$3,905,899
Arnon Rosenthal	Co-founder, Chief Executive Officer	$621,413	—	$1,694,939	$800,515	$389,340	$9,191	$3,515,398
Robert King	Former Chief Development Officer	$385,273	—	$204,109	$96,400	—	$6,935	$692,718
Linda Rubinstein	—	$116,400	—	—	—	—	—	$116,400

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	Co-founder, Chief Executive Officer	$575,400	—	$1,801,875	$6,837,954	$388,160	$9,191	$9,612,580
Shehnaaz Suliman	Former President and Chief Operating Officer	$500,000	—	$1,201,250	$816,282	—	$773,225	$3,290,757
Robert King	Former Chief Development Officer	$437,500	—	$681,317	$584,043	$214,016	$7,322	$1,924,198
Calvin Yu	Vice President, Finance	$308,333	$90,000	$470,722	$385,238	$114,576	$6,784	$1,375,653
Robert Paul	M.D., Ph.D. Former ChiefMedicalOfficer	$366,699	—	$720,750	—	—	$38,866	$1,126,315
Dr. Sara Kenkare-Mitra	President and Head of Research and Development	$25,942	$500,000	—	—	$26,813	$28	$526,841
Linda Rubinstein	—	$306,150	—	—	—	—	—	$306,150

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shehnaaz Suliman	Former President and Chief Operating Officer	$471,667	—	—	$7,667,378	$200,250	$5,841	$8,345,136
Arnon Rosenthal	Co-founder, Chief Executive Officer, and Director	$554,167	—	—	$3,096,204	—	$11,858	$3,662,229
Robert King	Former Chief Development Officer	$414,583	—	—	$835,973	$134,300	$7,322	$1,392,178
Robert Paul	M.D., Ph.D. Former ChiefMedicalOfficer	$432,017	—	—	$743,088	$130,240	$6,242	$1,311,587
Calvin Yu	Vice President, Finance	$295,000	—	—	$457,455	$71,100	$4,771	$828,326

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	Co-founder, Chief Executive Officer, and Director	$525,000	—	—	$5,984,524	$341,250	$3,564	$6,854,338
Robert Paul	M.D., Ph.D. Former ChiefMedicalOfficer	$392,100	—	—	$1,726,305	$188,208	$1,242	$2,307,855
Robert King	Chief Development Officer	$362,500	—	—	$1,726,305	$166,750	$2,322	$2,257,877

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	Co-founder, Chief Executive Officer, and Director	$396,764	—	—	$4,816,115	$237,540	$3,564	$5,453,983
Robert Paul	M.D., Ph.D. Chief Medical Officer	$326,367	$43,750	—	$2,707,815	$136,920	$1,243	$3,216,095
Robert King	Chief Development Officer	$352,297	—	—	$1,570,355	$147,800	$2,323	$2,072,775

Executive changes

Person	Role	Change	Effective	Filed
Neil Berkley	Chief Financial Officer	Appointed	2025-12-10	2025-12-12
Sara Kenkare-Mitra, Ph.D.	President and Head of Research and Development	Resigned	2025-12-22	2025-10-21
Grace Wong-Sarad	Vice President, Accounting	Appointed	2025-06-20	2025-06-13
Neil Berkley	Interim Chief Financial Officer	Appointed	2025-06-20	2025-06-13
Marc Grasso	Chief Financial Officer	Resigned	2025-06-20	2025-06-13
Dr. Gary Romano	Chief Medical Officer	Resigned	2025-04-25	2025-03-28
Mark Altmeyer	Class III director	Appointed	2024-03-19	2024-03-21
Errol De Souza, Ph.D.	Class II director	Appointed	2024-03-19	2024-03-21
Terry McGuire	member of the Board of Directors	Resigned	2024-03-20	2024-03-21
Tillman Gerngross, Ph.D.	director of the Board	Resigned	2023-06-15	2023-04-27
Tillman Gerngross, Ph.D.	Chairperson of the Company's board of directors	Resigned	2023-06-13	2023-04-27
Robert King, Ph.D.	Chief Development Officer	Resigned	2022-10-28	2022-10-06

Leadership

Arnon Rosenthal CEO, Board Member
Marc Grasso, M.D. CFO
Neil Berkley CFO
Shehnaaz Suliman COO
Grace Wong-Sarad Chief Accounting Officer
Linda Rubinstein Chief Accounting Officer
Continuing Directors Board Member
Dr. Paula Hammond Board Member
Elizabeth A. Garofalo, M.D. Board Member
Elizabeth Garofalo Board Member
Errol De Souza Board Member
Errol De Souza, Ph.D. Board Member
Kristine Yaffe Board Member
Louis J. Lavigne Board Member
Mark Altmeyer Board Member
Paula Hammond Board Member
Richard H. Scheller Board Member

Key facts CIK 1653087 CUSIP 014442107 13F (30d) 17 filings 15 filers Visit website Investor relations